Sarepta Therapeutics
SRPT
SRPT
310 hedge funds and large institutions have $1.73B invested in Sarepta Therapeutics in 2025 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 106 increasing their positions, 102 reducing their positions, and 105 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
14% less funds holding
Funds holding: 359 → 310 (-49)
38% less first-time investments, than exits
New positions opened: 65 | Existing positions closed: 105
Holders
310
Holding in Top 10
–
Calls
$134M
Puts
$144M
Top Buyers
| 1 | +$42.3M | |
| 2 | +$39M | |
| 3 | +$31.9M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$28.7M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$25.3M |
Top Sellers
| 1 | -$47.6M | |
| 2 | -$43.3M | |
| 3 | -$27.3M | |
| 4 |
CC
Casdin Capital
New York
|
-$16.9M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$16.2M |
